XML 23 R13.htm IDEA: XBRL DOCUMENT v3.19.2
Note 7 - Stock-based Compensation
6 Months Ended
Jun. 30, 2019
Notes to Financial Statements  
Shareholders' Equity and Share-based Payments [Text Block]
7.
   
STOCK-BASED COMPENSATION
 
We recorded non-cash stock compensation expense in each period as follows:
 
   
Three-month period ended
   
Six-month period ended
 
   
June 30,
   
July 1,
   
June 30,
   
July 1,
 
   
2019
   
2018
   
2019
   
2018
 
Stock options
  $
142
    $
186
    $
316
    $
309
 
Restricted stock grants
   
33
     
19
     
44
     
35
 
Total
  $
175
    $
205
    $
360
    $
344
 
 
We have stock options outstanding from various stock-based employee compensation plans for which we record compensation cost relating to share-based payment transactions in our financial statements. As of
June 30, 2019,
there was
$284
of total unrecognized compensation cost related to outstanding stock options, which is expected to be recognized over a weighted average period of
1.1
years.
 
The following table summarizes stock option activity for the
six
-month period ended
June 30, 2019:
 
   
Number of
Shares
   
Weighted
Average
Exercise
Price
   
Weighted
Average
Remaining
Contractual
Term (years)
   
Aggregate
Intrinsic
Value
 
Outstanding at January 1, 2019
   
1,576,087
    $
6.58
     
 
     
 
 
Granted
   
-
     
-
     
 
     
 
 
Exercised
   
(104,587
)    
4.56
     
 
     
 
 
Forfeited or expired
   
(6,916
)    
4.59
     
 
     
 
 
Outstanding at June 30, 2019
   
1,464,584
    $
6.74
     
3.03
    $
2,917
 
Vested and expected to vest at June 30, 2019
   
1,409,866
    $
6.69
     
2.94
    $
2,860
 
Exercisable at June 30, 2019
   
1,189,793
    $
6.13
     
2.65
    $
2,704
 
 
Cash received from stock option exercises under our stock-based compensation plans for the
three
-month periods ended
June 30, 2019
and
July 1, 2018
was
$122
and
$354,
respectively. Cash received from stock option exercises under our stock-based compensation plans for the
six
-month periods ended
June 30, 2019
and
July 1, 2018
was
$478
and
$1,293,
respectively.
 
In
April 2019,
20,000
shares of restricted stock were awarded to certain of our employees at a weighted-average grant date fair value of
$11.12
per share. In
January 2018,
17,500
shares of restricted stock were awarded to certain of our employees at a weighted-average grant date fair value of
$7.16
per share. All outstanding restricted shares vest in equal annual installments over
three
years. Unrecognized compensation cost related to these restricted shares was
$230
at
June 30, 2019.